Literature DB >> 24370595

Intraluminal negative pressure wound therapy for optimizing pharyngeal reconstruction.

Scott A Asher1, Hilliary N White1, Elisa A Illing1, William R Carroll1, J Scott Magnuson1, Eben L Rosenthal1.   

Abstract

IMPORTANCE: Pharyngocutaneous fistula formation after pharyngeal reconstruction is one of the most common and challenging problems to manage. Despite many advances in management, the published success rates indicate a role for any adjuvant therapy that could potentially decrease this complication.
OBJECTIVE: To describe the use of intraluminal negative pressure dressings (NPDs) in pharyngeal reconstruction. DESIGN, SETTING, AND PARTICIPANTS: Retrospective case series at a tertiary care academic hospital. Twelve laryngectomy patients underwent pharyngeal reconstruction augmented by placement of an intrapharyngeal NPD in combination with the introduction of vascularized tissue from August 2011 to May 2012. All patients had potential risk factors for compromised wound healing defined as previous radiation therapy, hypothyroidism, diabetes mellitus, compromised nutrition, or established pharyngocutaneous fistula.
INTERVENTIONS: An NPD was placed in an intraluminal position spanning the length of the pharyngeal defect as part of the reconstructive procedure. The negative pressure sponge was attached to a standard nasogastric tube to which negative pressure was applied. External closure of the pharynx was then achieved with regional or free tissue transfer. MAIN OUTCOMES AND MEASURES: Pharyngeal closure rates, timing until return to oral diet, identification of wound healing risk factors, and adverse events related to use of the device.
RESULTS: Eleven of 12 patients (92%) achieved pharyngeal closure with reconstruction using negative pressure wound therapy. All patients had at least 1 potential risk factor for compromised wound healing, with 11 of 12 (92%) having 2 or more. Seven patients had an established pharyngocutaneous fistula, and 5 patients underwent primary reconstruction after laryngopharyngectomy. In 6 of these 7 patients undergoing fistula repair, pharyngeal closure was achieved, and they resumed an oral diet at 1 week postoperatively. The other had successful leak repair initially, but 1 week later developed a separate area of wound breakdown and a second fistula. All 5 patients in whom an intraluminal NPD was placed at the time of initial vacularized tissue reconstruction were able to resume an oral diet by 3 weeks postoperatively, with 3 of them eating by mouth at 1 week postoperatively. No serious adverse events could be attributed to the use of intraluminal NPDs. CONCLUSIONS AND RELEVANCE: Intraluminal negative pressure wound therapy is feasible and safe. Future research should be conducted to determine its potential in optimizing pharyngeal reconstruction in high-risk patients.

Entities:  

Mesh:

Year:  2014        PMID: 24370595     DOI: 10.1001/jamaoto.2013.6143

Source DB:  PubMed          Journal:  JAMA Otolaryngol Head Neck Surg        ISSN: 2168-6181            Impact factor:   6.223


  5 in total

1.  Systematic review of negative pressure wound therapy for head and neck wounds with fistulas: Outcomes and complications.

Authors:  Fu-Yu Lin; Pin-Yi Huang; Hsu-Tang Cheng
Journal:  Int Wound J       Date:  2019-11-06       Impact factor: 3.315

Review 2.  Non-Surgical Strategies for Assisting Closure of Pharyngocutaneous Fistula after Total Laryngectomy: A Systematic Review of the Literature.

Authors:  Luca Giovanni Locatello; Giuseppe Licci; Giandomenico Maggiore; Oreste Gallo
Journal:  J Clin Med       Date:  2021-12-24       Impact factor: 4.241

3.  Immediate application of negative pressure wound therapy following lower extremity flap reconstruction in sixteen patients.

Authors:  Chun-Yu Chen; Shyh-Ming Kuo; Yih-Wen Tarng; Kai-Cheng Lin
Journal:  Sci Rep       Date:  2021-10-27       Impact factor: 4.379

Review 4.  Impact of Previous Irradiation on Wound Healing after Negative Pressure Wound Therapy in Head and Neck Cancer Patients-A Systematic Review.

Authors:  Muhammad Faisal; Peter D Berend; Rudolf Seemann; Stefan Janik; Stefan Grasl; Andrea Ritzengruber; Herbert Mendel; Arif Jamshed; Raza Hussain; Boban M Erovic
Journal:  Cancers (Basel)       Date:  2021-05-19       Impact factor: 6.639

Review 5.  Modified vacuum-assisted closure (EndoVAC) therapy for treatment of pharyngocutaneous fistula: Case series and a review of the literature.

Authors:  Teresa Bernadette Steinbichler; Dolores Wolfram; Annette Runge; Roland Hartl; Daniel Dejaco; Tina Rauchenwald; Claus Pototschnig; Herbert Riechelmann; Volker Hans Schartinger
Journal:  Head Neck       Date:  2021-04-08       Impact factor: 3.821

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.